Finding aptamers and small ribozymes in unexpected places

Wiley Interdisciplinary Reviews: RNA

Volumn 3, Issue 1, 2012, Pages 73-91

  Matylla Kulinska, Katarzyna ^a   Boots, Jennifer L ^a   Zimmermann, Bob ^a   Schroeder, Renée ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; RIBOZYME; RNA; TRANSCRIPTOME;

BIOINFORMATICS; GENE AMPLIFICATION; GENE SEQUENCE; GENOMICS; HUMAN; IN VITRO STUDY; METAGENOME; NONHUMAN; PRIORITY JOURNAL; REVIEW;

APTAMERS, NUCLEOTIDE; HUMANS; RIBOSWITCH; RNA, CATALYTIC; SELEX APTAMER TECHNIQUE;

EID: 84867591926     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.105     Document Type: Review

References (131)

1. Raney BJ, Cline MS, Rosenbloom KR, Dreszer TR, Learned K, Barber GP, Meyer LR, Sloan CA, Malladi VS, Roskin KM, et al. ENCODE whole-genome data in the UCSC genome browser (2011 update). Nucleic Acids Res 2011, 39:871-875.
2. Johnson JM, Edwards S, Shoemaker D, Schadt EE. Dark matter in the genome: evidence of widespread transcription detected by microarray tiling experiments. Trends Genet 2005, 21:93-102.
3. Doudna JA, Cech TR. The chemical repertoire of natural ribozymes. Nature 2002, 418:222-228.
4. Jäschke A. Artificial ribozymes and deoxyribozymes. Curr Opin Struct Biol 2001, 11:321-326.
5. Werstuck G, Green MR. Controlling gene expression in living cells through small molecule-RNA interactions. Science 1998, 282:296-298.
6. Suess B, Hanson S, Berens C, Fink B, Schroeder R, Hillen W. Conditional gene expression by controlling translation with tetracycline-binding aptamers. Nucleic Acids Res 2003, 31:1853-1858.
7. Bass BL, Cech TR. Specific interaction between the self-splicing RNA of Tetrahymena and its guanosine substrate: implications for biological catalysis by RNA. Nature 1984, 308:820-826.
8. Yarus M. A specific amino acid binding site composed of RNA. Science 1988, 240:1751-1758.
9. von Ahsen U, Davies J, Schroeder R: antibiotic inhibition of group I ribozyme function. Nature 1991, 353:368-370.
10. Hermann T, Patel DJ. Adaptive recognition by nucleic acid aptamers. Science 2000, 287:820-825.
11. Mironov AS, Gusarov I, Rafikov R, Lopez LE, Shatalin K, Kreneva RA, Perumov DA, Nudler E. Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria. Cell 2002, 111:747-756.
12. Winkler WC, Cohen-Chalamish S, Breaker RR. An mRNA structure that controls gene expression by binding FMN. Proc Natl Acad Sci U S A 2002, 99: 15908-15913.
13. Nahvi A, Sudarsan N, Ebert MS, Zou X, Brown KL, Breaker RR. Genetic control by a metabolite binding mRNA. Chem Biol 2002, 9:1043-1049.
14. Mendonsa SD, Bowser MT. In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal Chem 2004, 76:5387-5392.
15. Lorenz C, Gesell T, Zimmermann B, Schoeberl U, Bilusic I, Rajkowitsch L, Waldsich C, von Haeseler A, Schroeder R. Genomic SELEX for Hfq-binding RNAs identifies genomic aptamers predominantly in antisense transcripts. Nucleic Acids Res 2010, 38: 3794-3808.
16. Watrin M, Von Pelchrzim F, Dausse E, Schroeder R, Toulmé JJ. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1. Biochemistry 2009, 48:6278-6284.
17. Hofmann HP, Limmer S, Hornung V, Sprinzl M. Ni2+-binding RNA motifs with an asymmetric purine-rich internal loop and a G-A base pair. RNA 1997, 3: 1289-1300.
18. Sazani PL, Larralde R, Szostak JW. A small aptamer with strong and specific recognition of the triphosphate of ATP. J Am Chem Soc 2004, 126:8370-8371.
19. Niazi JH, Lee SJ, Gu MB. Single-stranded DNA aptamers specific for antibiotics tetracyclines. Bioorg Med Chem 2008, 16:7245-7253.
20. Gopinath SC, Misono TS, Kawasaki K, Mizuno T, Imai M, Odagiri T, Kumar PK. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J Gen Virol 2006, 87:479-487.
21. Lee YJ, Seong-Wook L. In vitro Selection of Cancer-Specific RNA Aptamers. J Microbiol Biotechnol 2006, 16:1149-1153.
22. Fisher TS, Joshi P, Prasad VR. Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication. J Virol 2002, 76:4068-4072.
23. Jenison RD, Gill SC, Pardi A, Polisky B. High-resolution molecular discrimination by RNA. Science 1994, 263:1425-1429.
24. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
25. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249: 505-510.
26. Hirao I, Harada Y, Nojima T, Osawa Y, Masaki H, Yokoyama S. In vitro selection of RNA aptamers that bind to colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA. Biochemistry 2004, 43: 3214-3221.
27. Vater A, Jarosch F, Buchner K, Klussmann S. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. Nucleic Acids Res 2003, 31:130.
28. Tang J, Xie J, Shao N, Yan Y. The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods. Electrophoresis 2006, 27:1303-1311.
29. Lozupone C, Changayil S, Majerfeld I, Yarus M. Selection of the simplest RNA that binds isoleucine. RNA 2003, 9:1315-1322.
30. Gopinath SC, Kawasaki K, Kumar PK. Selection of RNA-aptamer against human influenza B virus. Nucleic Acids Symp Ser (Oxf) 2005:85-86.
31. Jensen KB, Atkinson BL, Willis MC, Koch TH, Gold L. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci U S A 1995, 92:12220-12224.
32. Yao W, Adelman K, Bruenn JA. In vitro selection of packaging sites in a double-stranded RNA virus. J Virol 1997, 71:2157-2162.
33. Berezovski MV, Musheev MU, Drabovich AP, Jitkova JV, Krylov SN. Non-SELEX: selection of aptamers without intermediate amplification of candidate oligonucleotides. Nat Protoc 2006, 1:1359-1369.
34. Mayer G, Ahmed MS, Dolf A, Endl E, Knolle PA, Famulok M. Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nat Protoc 2010, 5:1993-2004.
35. Tsuji S, Hirabayashi N, Kato S, Akitomi J, Egashira H, Tanaka T, Waga I, Ohtsu T. Effective isolation of RNA aptamer through suppression of PCR bias. Biochem Biophys Res Commun 2009, 386:223-226.
36. Zimmermann B, Gesell T, Chen D, Lorenz C, Schroeder R. Monitoring genomic sequences during SELEX using high-throughput sequencing: neutral SELEX. PLoS One 2010, 5:e9169.
37. Tereshko V, Skripkin E, Patel DJ. Encapsulating streptomycin within a small 40-mer RNA. Chem Biol 2003, 10:175-187.
38. Mosing RK, Mendonsa SD, Bowser MT. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 2005, 77:6107-6112.
39. Collett JR, Cho EJ, Ellington AD. Production and processing of aptamer microarrays. Methods 2005, 37:4-15.
40. Chushak Y, Stone MO. In silico selection of RNA aptamers. Nucleic Acids Res 2009, 37:e87.
41. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008, 26:1135-1145.
42. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
43. Grundy FJ, Henkin TM. The S box regulon: a new global transcription termination control system for methionine and cysteine biosynthesis genes in gram-positive bacteria. Mol Microbiol 1998, 30:737-749.
44. Yao Z, Weinberg Z, Ruzzo WL. CMfinder-a covariance model based RNA motif finding algorithm. Bioinformatics 2006, 22:445-452.
45. Weinberg Z, Barrick JE, Yao Z, Roth A, Kim JN, Gore J, Wang JX, Lee ER, Block KF, Sudarsan N, et al. Identification of 22 candidate structured RNAs in bacteria using the CMfinder comparative genomics pipeline. Nucleic Acids Res 2007, 35:4809-4819.
46. Weinberg Z, Wang JX, Bogue J, Yang J, Corbino K, Moy RH, Breaker RR. Comparative genomics reveals 104 candidate structured RNAs from bacteria, archaea, and their metagenomes. Genome Biol 2010, 11:R31.
47. Yao Z, Barrick J, Weinberg Z, Neph S, Breaker R, Tompa M, Ruzzo WL. A computational pipeline for high- throughput discovery of cis-regulatory noncoding RNA in prokaryotes. PLoS Comput Biol 2007, 3:e126.
48. Barrick JE, Breaker RR. The distributions, mechanisms, and structures of metabolite-binding riboswitches. Genome Biol 2007, 8:R239.
49. Sudarsan N, Hammond MC, Block KF, Welz R, Barrick JE, Roth A, Breaker RR. Tandem riboswitch architectures exhibit complex gene control functions. Science 2006, 314:300-304.
50. Mandal M, Lee M, Barrick JE, Weinberg Z, Emilsson GM, Ruzzo WL, Breaker RR. A glycine-dependent riboswitch that uses cooperative binding to control gene expression. Science 2004, 306:275-279.
51. Sudarsan N, Barrick JE, Breaker RR. Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA 2003, 9:644-647.
52. Bocobza S, Adato A, Mandel T, Shapira M, Nudler E, Aharoni A. Riboswitch-dependent gene regulation and its evolution in the plant kingdom. Genes Dev 2007, 21:2874-2879.
53. Wachter A, Tunc-Ozdemir M, Grove BC, Green PJ, Shintani DK, Breaker RR. Riboswitch control of gene expression in plants by splicing and alternative 3' end processing of mRNAs. Plant Cell 2007, 19: 3437-3450.
54. Kubodera T, Watanabe M, Yoshiuchi K, Yama- shita N, Nishimura A, Nakai S, Gomi K, Hanamoto H. Thiamine-regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch-like domain in the 5'-UTR. FEBS Lett 2003, 555:516-520.
55. Cheah MT, Wachter A, Sudarsan N, Breaker RR. Control of alternative RNA splicing and gene expression by eukaryotic riboswitches. Nature 2007, 447:497-500.
56. Winkler WC, Nahvi A, Roth A, Collins JA, Breaker RR. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 2004, 428: 281-286.
57. Joyce GF. The antiquity of RNA-based evolution. Nature 2002, 418:214-221.
58. Mandal M, Boese B, Barrick JE, Winkler WC, Breaker RR. Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 2003, 113:577-586.
59. Bohn C, Rigoulay C, Chabelskaya S, Sharma CM, Marchais A, Skorski P, Borezée-Durant E, Barbet R, Jacquet E, Jacq A, et al. Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism. Nucleic Acids Res 2010, 38:6620-6636.
60. Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, Balestrino D, Loh E, Gripenland J, Tiensuu T, Vaitkevicius K, et al. The Listeria transcriptional landscape from saprophytism to virulence. Nature 2009, 459:950-956.
61. Loh E, Dussurget O, Gripenland J, Vaitkevicius K, Tiensuu T, Mandin P, Repoila F, Buchrieser C, Cossart P, Johansson J. A trans-acting riboswitch controls expression of the virulence regulator PrfA in Listeria monocytogenes. Cell 2009, 139:770-779.
62. Bengert P, Dandekar T. Riboswitch finder-a tool for identification of riboswitch RNAs. Nucleic Acids Res 2004, 32:W154-W159.
63. Chang TH, Huang HD, Wu LC, Yeh CT, Liu BJ, Horng JT. Computational identification of riboswitches based on RNA conserved functional sequences and conformations. RNA 2009, 15: 1426-1430.
64. Eddy SR, Durbin R. RNA sequence analysis using covariance models. Nucleic Acids Res 1994, 22: 2079-2088.
65. Gardner PP, Daub J, Tate JG, Nawrocki EP, Kolbe DL, Lindgreen S, Wilkinson AC, Finn RD, Griffiths-Jones S, Eddy SR, Bateman A. Rfam: updates to the RNA families database. Nucleic Acids Res 2009, 37: D136-D140.
66. Nawrocki EP, Kolbe DL, Eddy SR. Infernal 1.0: inference of RNA alignments. Bioinformatics 2009, 25: 1335-1337.
67. Abreu-Goodger C, Ontiveros-Palacios N, Ciria R, Merino E. Conserved regulatory motifs in bacteria: riboswitches and beyond. Trends Genet 2004, 20: 475-479.
68. Abreu-Goodger C, Merino E. RibEx: a web server for locating riboswitches and other conserved bacterial regulatory elements. Nucleic Acids Res 2005, 33: W690-692.
69. Lyngsø RB, Pedersen CN. RNA pseudoknot prediction in energy-based models. J Comput Biol 2000, 7: 409-427.
70. Meyer MM, Hammond MC, Salinas Y, Roth A, Sudarsan N, Breaker RR. Challenges of ligand identification for riboswitch candidates. RNA Biol 2011, 8: 5-10.
71. Zimmermann B, Bilusic I, Lorenz C, Schroeder R. Genomic SELEX: a discovery tool for genomic aptamers. Methods 2010, 52:125-132.
72. Lorenz C, von Pelchrzim F, Schroeder R. Genomic systematic evolution of ligands by exponential enrichment (Genomic SELEX) for the identification of protein-binding RNAs independent of their expression levels. Nat Protoc 2006, 1:2204-2212.
73. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
74. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
75. Green RE, Krause J, Ptak SE, Briggs AW, Ronan MT, Simons JF, Du L, Egholm M, Rothberg JM, Paunovic M, Pääbo S. Analysis of one million base pairs of Neanderthal DNA. Nature 2006, 444: 330-336.
76. Noonan JP, Coop G, Kudaravalli S, Smith D, Krause J, Alessi J, Chen F, Platt D, Pääbo S, Pritchard JK, Rubin EM. Sequencing and analysis of Neanderthal genomic DNA. Science 2006, 314:1113-1118.
77. Zaug AJ, Cech TR. In vitro splicing of the ribosomal RNA precursor in nuclei of Tetrahymena. Cell 1980, 19:331-338.
78. Cech TR, Zaug AJ, Grabowski PJ. In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 1981, 27:487-496.
79. Peebles CL, Perlman PS, Mecklenburg KL, Petrillo ML, Tabor JH, Jarrell KA, Cheng HL. A self-splicing RNA excises an intron lariat. Cell 1986, 44:213-223.
80. van der Veen R, Arnberg AC, van der Horst G, Bonen L, Tabak HF, Grivell LA. Excised group II introns in yeast mitochondria are lariats and can be formed by self-splicing in vitro. Cell 1986, 44: 225-234.
81. Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 1983, 35:849-857.
82. Michel F, Umesono K, Ozeki H. Comparative and functional anatomy of group II catalytic introns-a review. Gene 1989, 82:5-30.
83. Symons RH. Small catalytic RNAs. Annu Rev Biochem 1992, 61:641-671.
84. Feldstein PA, Buzayan JM, Bruening G. Two sequences participating in the autolytic processing of satellite tobacco ringspot virus complementary RNA. Gene 1989, 82:53-61.
85. Haseloff J, Gerlach WL. Sequences required for self-catalysed cleavage of the satellite RNA of tobacco ringspot virus. Gene 1989, 82:43-52.
86. Prody GA, Bakos JT, Buzayan JM, Schneider IR, Bruening G. Autolytic processing of dimeric plant virus satellite RNA. Science 1986, 231:1577-1580.
87. Sharmeen L, Kuo MY, Dinter-Gottlieb G, Taylor J. Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol 1988, 62:2674-2679.
88. Saville BJ, Collins RA. A site-specific self-cleavage reaction performed by a novel RNA in Neurospora mitochondria. Cell 1990, 61:685-696.
89. de la Peña M, García-Robles I. Ubiquitous presence of the hammerhead ribozyme motif along the tree of life. RNA 2010, 16:1943-1950.
90. Ferré-D'Amaré AR, Scott WG. Small self-cleaving ribozymes. Cold Spring Harb Perspect Biol 2010, 2:a003574.
91. Martick M, Scott WG. Tertiary contacts distant from the active site prime a ribozyme for catalysis. Cell 2006, 126:309-320.
92. Khvorova A, Lescoute A, Westhof E, Jayasena SD. Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity. Nat Struct Biol 2003, 10:708-712.
93. De la Peña M, Gago S, Flores R. Peripheral regions of natural hammerhead ribozymes greatly increase their self-cleavage activity. EMBO J 2003, 22:5561-5570.
94. Boots JL, Canny MD, Azimi E, Pardi A. Metal ion specificities for folding and cleavage activity in the Schistosoma hammerhead ribozyme. RNA 2008, 14: 2212-2222.
95. Przybilski R, Gräf S, Lescoute A, Nellen W, Westhof E, Steger G, Hammann C. Functional hammerhead ribozymes naturally encoded in the genome of Arabidopsis thaliana. Plant Cell 2005, 17:1877-1885.
96. de la Peña M, García-Robles I. Intronic hammerhead ribozymes are ultraconserved in the human genome. EMBO Rep 2010, 11:711-716.
97. Martick M, Horan LH, Noller HF, Scott WG. A discontinuous hammerhead ribozyme embedded in a mammalian messenger RNA. Nature 2008, 454: 899-902.
98. Yen L, Svendsen J, Lee JS, Gray JT, Magnier M, Baba T, D'Amato RJ, Mulligan RC. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature 2004, 431:471-476.
99. Breaker RR. Natural and engineered nucleic acids as tools to explore biology. Nature 2004, 432:838-845.
100. Lee ER, Baker JL, Weinberg Z, Sudarsan N, Breaker RR. An allosteric self-splicing ribozyme triggered by a bacterial second messenger. Science 2010, 329: 845-848.
101. Salehi-Ashtiani K, Lupták A, Litovchick A, Szostak JW. A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene. Science 2006, 313:1788-1792.
102. Chadalavada DM, Gratton EA, Bevilacqua PC. The human HDV-like CPEB3 ribozyme is intrinsically fast-reacting. Biochemistry 2010, 49:5321-5330.
103. Dsouza M, Larsen N, Overbeek R. Searching for patterns in genomic data. Trends Genet 1997, 13: 497-498.
104. Ferbeyre G, Bourdeau V, Pageau M, Miramontes P, Cedergren R. Distribution of hammerhead and hammerhead-like RNA motifs through the GenBank. Genome Res 2000, 10:1011-1019.
105. Seehafer C, Kalweit A, Steger G, Gräf S, Hammann C. From alpaca to zebrafish: hammerhead ribozymes wherever you look. RNA 2011, 17:21-26.
106. Jimenez RM, Delwart E, Lupták A. Structure-based search reveals hammerhead ribozymes in the human microbiome. J Biol Chem 2011, 286:7737-7743.
107. Hofacker IL, Fontana W, Stadler PF, Bonhoeffer LS, Tacker M, Schuster P. Fast folding and comparison of RNA secondary structures. Monatsh Chem 1994, 125:167-188.
108. Eckstein F, Kore AR, Nakamaye KL. In vitro selection of hammerhead ribozyme sequence variants. Chembiochem 2001, 2:629-635.
109. Salehi-Ashtiani K, Szostak JW. In vitro evolution suggests multiple origins for the hammerhead ribozyme. Nature 2001, 414:82-84.
110. Wright MC, Joyce GF. Continuous in vitro evolution of catalytic function. Science 1997, 276:614-617.
111. Thomson JB, Sigurdsson ST, Zeuch A, Eckstein F. In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II. Nucleic Acids Res 1996, 24:4401-4406.
112. Sargueil B, Burke JM. In vitro selection of hairpin ribozymes. Methods Mol Biol 1997, 74:289-300.
113. Jayasena VK, Gold L. In vitro selection of self-cleaving RNAs with a low pH optimum. Proc Natl Acad Sci U S A 1997, 94:10612-10617.
114. Vaish NK, Heaton PA, Eckstein F. Isolation of hammerhead ribozymes with altered core sequences by in vitro selection. Biochemistry 1997, 36:6495-6501.
115. Conaty J, Hendry P, Lockett T. Selected classes of minimised hammerhead ribozyme have very high cleavage rates at low Mg2+ concentration. Nucleic Acids Res 1999, 27:2400-2407.
116. Tuschl T, Sharp PA, Bartel DP. Selection in vitro of novel ribozymes from a partially randomized U2 and U6 snRNA library. EMBO J 1998, 17:2637-2650.
117. Zillmann M, Limauro SE, Goodchild J. In vitro optimization of truncated stem-loop II variants of the hammerhead ribozyme for cleavage in low concentrations of magnesium under non-turnover conditions. RNA 1997, 3:734-747.
118. Drude I, Strahl A, Galla D, Müller O, Müller S. Design of hairpin ribozyme variants with improved activity for poorly processed substrates. FEBS J 2011, 278: 622-633.
119. Müller S. Engineered ribozymes as molecular tools for site-specific alteration of RNA sequence. Chembiochem 2003, 4:991-997.
120. Meli M, Vergne J, Maurel MC. In vitro selection of adenine-dependent hairpin ribozymes. J Biol Chem 2003, 278:9835-9842.
121. Li YL, Vergne J, Torchet C, Maurel MC. In vitro selection of adenine-dependent ribozyme against Tpl2/Cot oncogene. FEBS J 2009, 276:303-314.
122. Soukup GA, Breaker RR. Design of allosteric hammerhead ribozymes activated by ligand-induced structure stabilization. Structure 1999, 7:783-791.
123. Tang J, Breaker RR. Rational design of allosteric ribozymes. Chem Biol 1997, 4:453-459.
124. Ausländer S, Ketzer P, Hartig JS. A ligand-dependent hammerhead ribozyme switch for controlling mammalian gene expression. Mol Biosyst 2010, 6: 807-814.
125. Piganeau N. In vitro selection of allosteric ribozymes. Methods Mol Biol 2009, 535:45-57.
126. Wilson C, Szostak JW. In vitro evolution of a self-alkylating ribozyme. Nature 1995, 374:777-782.
127. Unrau PJ, Bartel DP. RNA-catalysed nucleotide synthesis. Nature 1998, 395:260-263.
128. Zhang B, Cech TR. Peptide bond formation by in vitro selected ribozymes. Nature 1997, 390:96-100.
129. Agresti JJ, Kelly BT, Jäschke A, Griffiths AD. Selection of ribozymes that catalyse multiple-turnover Diels-Alder cycloadditions by using in vitro compartmentalization. Proc Natl Acad Sci U S A 2005, 102:16170-16175.
130. Zaher HS, Unrau PJ. Selection of an improved RNA polymerase ribozyme with superior extension and fidelity. RNA 2007, 13:1017-1026.
131. Wochner A, Attwater J, Coulson A, Holliger P. Ribozyme-catalyzed transcription of an active ribozyme. Science 2011, 332:209-212.